Imran Khan - 13 Feb 2026 Form 4 Insider Report for Proem Acquisition Corp. I (PAAC)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
04 Mar 2026, 18:43:47 UTC
Prior SEC filing
11 Feb 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Imran Khan

Key filing fact

Imran Khan filed Form 4 for Proem Acquisition Corp. I (PAAC) on 04 Mar 2026.

Key facts

  • This page summarizes Imran Khan's Form 4 filing for Proem Acquisition Corp. I (PAAC).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 04 Mar 2026, 18:43.

Change

  • Previous filing in this sequence was filed on 11 Feb 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001699292 Primary reporting owner

Khan Imran

Relationship
Chief Executive Officer, Director, 10%+ Owner
Address
C/O PROEM ACQUISITION CORP I, 3860 W. NORTHWEST HWY, SUITE 470, DALLAS
Signature
/s/ Imran Khan
Signature date
04 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PAAC transaction

Ordinary Shares

Purchase

Transaction value
Shares
+292,500
Change %
+6.8%
Price
Shares after
4,625,833
Date
13 Feb 2026
Ownership
See Footnote
Footnotes
F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

PAAC transaction Derivative

Warrants to purchase Ordinary Shares

Purchase

Transaction value
Shares
+146,250
Change %
+45279%
Price
Shares after
146,573
Date
13 Feb 2026
Ownership
See Footnote
Underlying class
Ordinary Shares
Underlying amount
146,250
Exercise price
$11.50
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Proem SPAC Partners I LLC, the Issuer's sponsor (the "Sponsor"), purchased 4,983,333 ordinary shares for $25,000. Among which, 650,000 ordinary shares are subject to forfeited depending on the extent to which the underwriters' over-allotment option is exercised. Imran Khan is the managing member of the Sponsor and has voting and dispositive power over the shares owned by the Sponsor. Mr. Khan disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly

Footnote F2

Reflects the 292,500 private units owned by the Sponsor. Each private unit consists of one ordinary share and one-half of one redeemable warrant, with each whole warrant entitling the holder thereof to purchase one ordinary share for $11.50 per share, subject to adjustment. The private units were purchased pursuant to a Private Placement Units Purchase Agreement, dated February 11, 2026, by and between the Sponsor and the Issuer, at $10.00 per unit for an aggregate purchase price of $2,925,000.

Footnote F3

The warrants included in the private units will become exercisable on the later of (i) the completion of the Issuer's initial business combination, or (ii) February 11, 2027 (12 months after the Issuer's registration statement has been declared effective by the Securities and Exchange Commission), and will expire five years after the completion of the initial business combination or earlier upon redemption or liquidation.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .